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Mass spectrometry locates local and allosteric
conformational changes that occur on cofactor
binding
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Fdc1 is a decarboxylase enzyme that requires the novel prenylated FMN cofactor for activity.
Here, we use it as an exemplar system to show how native top-down and bottom-up mass
spectrometry can measure the structural effect of cofactor binding by a protein. For Fdc1Ubix,
the cofactor confers structural stability to the enzyme. IM–MS shows the holo protein to exist
in four closely related conformational families, the populations of which differ in the apo form;
the two smaller families are more populated in the presence of the cofactor and depopulated
in its absence. These findings, supported by MD simulations, indicate a more open structure
for the apo form. HDX-MS reveals that while the dominant structural changes occur proximal
to the cofactor-binding site, rearrangements on cofactor binding are evident throughout the
protein, predominantly attributable to allosteric conformational tightening, consistent with
IM–MS data.
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D
ecarboxylation reactions are common in nature,
despite the fact they are difficult to achieve under
ambient conditions. The reaction is made possible by
decarboxylase enzymes, often making use of cofactors, including
either organic molecules such as flavins, pyridoxal phosphate or
thiamine pyrophosphate, and/or metal ions, for example, Mg2þ ,
Fe2þ or Mn2þ (ref. 1). The recently discovered prenylated flavin
cofactor that features in the Pad1/Fdc1 and UbiX/UbiD
decarboxylase systems represents a new addition to this list2,3.
It has been previously demonstrated that both the fdc1 and
pad1 genes are essential for the decarboxylation of phenylacrylic
acids by spoilage yeasts and moulds such as Saccharomyces
cerevisiae and Aspergillus niger; however, the precise role of each
gene had remained enigmatic4,5. Recently, we have shown that
Fdc1 is in fact the enzyme responsible for decarboxylation,
although an active form of the recombinant protein can only be
obtained by co-expression with either pad1 or the corresponding
Escherichia coli homologue ubiX2. The co-expressed Fdc1 protein
(denoted Fdc1UbiX) possesses distinct features in the ultraviolet–
visible spectrum that are absent in single-expressed Fdc1.
Determination of the crystal structure of the A. niger Fdc1UbiX
revealed the presence of a modified flavin mononucleotide (FMN)
cofactor bound to the protein in complex with Mn2þ and Kþ .
This modified cofactor (prenylated FMN or prFMN) results from
addition of a prenyl group to the N5–C6 atoms of FMN to form
a fourth, non-aromatic ring. It is proposed that the prFMN
cofactor supports decarboxylation of substrate by dipolar 1,3
cycloaddition, given the azomethine ylide character. Subsequent
studies on UbiX/Pad have confirmed that these proteins
are responsible for prFMN synthesis3. While Fdc1UbiX could be
readily crystallized, no crystals were attainable from recombinant
Fdc1 produced in the absence of ubiX overexpression. It is
hypothesized that this is due to an increase in conformational
freedom of the apo protein, increasing the sampled
conformational heterogeneity and decreasing the likelihood of
crystallization. In this work, we present differences in the
conformational dynamics of Fdc1 on cofactor binding. In the
absence of any crystallographic reference structure for the apo
form, we use complementary mass spectrometry (MS)-based
approaches to determine the effect of prFMN binding; global
conformational change is assessed with ion mobility (IM)–MS,
whereas hydrogen–deuterium exchange-MS (HDX-MS) allows
the changes to be localized to regions of the Fdc1 dimer interface.
Molecular dynamics (MD) simulations were also carried out and
together these results indicate that the cofactor confers stability to
the enzyme.
With the use of nano-electrospray ionization (nESI)6, protein
complexes can retain their native topology and stoichiometry on
transfer into the gas phase7, an approach termed ‘native MS’8.
Following desolvation from aqueous solution, the ensuing
charge-state distribution provides mass and stoichiometric
information, and can be used to infer some conformational
preference for the protein or complex9. Native MS is highly
appropriate to examine dynamic properties of proteins: it has no
apparent bias towards a folded structure10. IM–MS facilitates
visualization of the shape distribution of a given protein or
protein complex in a form known as a collision cross section
distribution (CCSD), which provides direct information of the
size and conformational variability of a given system11. With
IM–MS, it is possible to separate multiple conformational
states12, for example, to observe how individual conformers are
affected by ligand binding13. This positions it as highly
complementary to X-ray crystallography; it cannot provide
atomistic detail, but it can report on structurally dynamic
systems and heterogeneic stoichiometries all in a single
experiment, which is not reliant on successful crystal formation.
HDX-MS is also complementary to IM–MS, since it can
also probe protein dynamics, allowing comparison between
conformational changes observed in vacuo to those in vitro.
When coupled with enzymatic digestion of the protein post
deuteration, it provides structural information at a more localized
level. A recent study carried out by Alverdi et al.14 used a
combination of native MS, IM–MS and HDX-MS to further
characterize the conformational rearrangement of PKG (cyclic
guanosine 30,50-monophosphate (cGMP)-dependent protein
kinase) in response to cGMP-dependent activation. IM results
suggested that cGMP binding to PKG promotes a more extended
structure, and HDX experiments allowed the localization of
conformational change to the different domains. Data obtained
from a combination of these MS techniques allowed the authors
to propose a new structural model for the cGMP-induced
activation of PKG.
In this work, we utilize three MS techniques, namely, native
MS, IM–MS and HDX-MS, to characterize the effects of the
prFMN cofactor, synthesized by the co-expressed enzyme (UbiX),
on the structure of the decarboxylase Fdc1. Our experimental
work is supported by MD simulations that examine the evolution
of the structure of Fdc1Ubix in the absence of solution and
consider the corresponding change in DTCCSHe. Both the
experiment and computation provide insights into the entire
conformational ensemble of this enzyme, both in its active and
inactive forms. This could not be achieved with standard
structural biology approaches, since the apo form did not
crystallize. The study emphasizes how MS can play a unique
role in dynamic structural science by identifying how prFMN
imprints new conformational properties into the Fdc1 protein.
Both the approach and observations are of general significance
within the context of the dynamic structure-defines-function
paradigm, and in particular highlight the capability of a MS
approach in establishing the role of cofactors on stabilising
protein structure.
Results
Native mass spectrometry of Fdc1 and of Fdc1Ubix. Native mass
spectra are shown in Fig. 1, of Fdc1 Fig. 1a and Fdc1UbiX Fig. 1b,
sprayed from physiological-like conditions (100mM ammonium
acetate, pH 6.8). These data were used to support our previous
study2. Fdc1, present only in the apo form, presents in charge
states [2Mþ 19H]19þ to [2Mþ 23H]23þ , with [2Mþ 21H]21þ
being the most intense. The native mass spectrum of Fdc1UbiX
shows a very slight narrowing in the charge-state distribution;
although the most abundant ion is still [2Mþ 21H]21þ , the
highest-charge state is now [2Mþ 22H]22þ . The first evidence in
the study for the stabilization of the dimer by the cofactor is
demonstrated by the monomer peaks in the Fdc1 spectrum,
whereas all of the Fdc1UbiX presents as a dimer. Whether these
dissociated subunits reflect the solution-phase properties or are
due to some dissociation of the complex in the mass
spectrometer, the presence of the monomer in only the Fdc1
spectrum strongly indicates that this dimer is less stable than that
of the Fdc1UbiX.
The Fdc1UbiX spectrum in Fig. 1b, predominantly shows a
species with two non-covalently bound cofactors. Approximately
one-third of the ion intensity is attributed to the protein with one
non-covalently bound cofactor and just a small amount of protein
is observed without any bound cofactor. This heterogeneity in the
protein complex may be due to incomplete cofactor occupancy in
solution or to loss of the cofactor on desolvation (vide infra).
The measured mass of the Fdc1 dimer expressed in the absence
of ubiX (112,266.4±1.5Da) is in close agreement to the predicted
mass of 112,270Da (Fig. 1a). The replete Fdc1UbiX bound to two
prFMN molecules, which is dominant in the native mass spectrum,
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(Fig. 1b) has a measured mass of 113,609±45.3Da, 294Da larger
than expected. Within the 4ZA4 structure, each monomer binds
one manganese and two potassium ions, as well as many waters,
and we can therefore attribute this extra mass to these six specified
metal adducts, as well as one or two retained water/buffer
molecules. Again, the crystallographic data that attributed electron
density to a manganese atom in each active site was supported by
electron paramagnetic resonance (EPR) experiments, where a
characteristic Mn2þ signal was observed in the EPR spectra of
Fdc1UbiX (ref. 2). The measured mass for the co-expressed protein
Fdc1UbiX with no prFMN bound is 112,369±87Da, slightly higher
than for singly expressed Fdc1. Here, the increase in mass of
B103Da would corresponds well to two manganese adducts.
When one cofactor is bound the difference between the expected
(112,870Da) and measured mass is higher again: B122Da above
what is predicted when the cofactor is in complex with the protein.
This could be attributed to the retention of three potassium ions or,
two waters and two potassium ions, as well as the two manganese
ions, suggesting that these are more strongly bound than prFMN,
and indicating that the prFMN depleted forms seen in MS indicate
that some of this molecule may be lost during the ESI process, a
point that we return to later.
Importantly, for all species, the predicted mass (with no
retention of salt) corresponds to the left hand side of the peak
(blue dashed lines, Fig. 1), while the apex of the peak corresponds
to the adducted forms discussed above. These spectra show
clearly that the Fdc1 dimer carries no cofactors and retains very
little salt, whereas Fdc1UbiX dimers carry either one or two
cofactors of 525Da along with a variety of unresolved adducts.
An increase in salt retention occurs with bound cofactors,
indicating that the addition of the cofactor favors the retention of
counter ions, some of which are evidenced in the crystal structure.
IM–MS reveals smaller conformers for Fdc1Ubix than for Fdc1.
DTCCSHe distributions of the three main charge states of Fdc1 are
shown in Fig. 2: Fdc1 (Fig. 2a) and the cofactor-bound forms of
Fdc1UbiX (Fig. 2b,c) and in Supplementary Fig. 1. The cross
sections of the [2Mþ 20H]20þ ions range from B4,000–
6,400Å2 for Fdc1, or B4,000–6,000Å2 for Fdc1UbiX, and the
apex of the distribution is just under 5,000Å2 for both forms of
the protein; for this charge state, there are only small differences
in the DTCCSHe distributions of Fdc1 and different forms of
Fdc1UbiX, and these indicate a compaction in the ligand-bound
form, the higher DTCCSHe distributions are not populated. For
[2Mþ 21H]21þ , the lower value for the ions isB4,200Å2 for all
species; however, there is a difference between the upper value of
Fdc1 (7,250Å2) and Fdc1UbiX (6,750Å2). The apex of the peak is
also different; for Fdc1, it isB5,250Å2, whereas for Fdc1UbiX it is
B4,800Å2. The differences in DTCCSHe distribution are most
prominent for the [2Mþ 22H]22þ ion: Fdc1UbiX displays two
conformers centred B4,900 and 5,600Å2, both at roughly
equal intensity; for Fdc1, however, the smaller conformer is
greatly reduced in intensity in comparison to the extended
state, indicating a destabilization of the compact conformation
in the absence of the cofactor. These IM–MS experiments
are in agreement with native MS data presented above, both
indicating a more compact structure in the presence of the
cofactor.
Gaussian curves were fitted to the most intense CCSDs for the
apo form and retained across other charge states and cofactor
stoichiometries to highlight the distinguishable conformations
with reference to the apo form. This procedure has been used
previously for protein complexes15 and monomeric proteins16,17.
The smallest conformer, shown by the purple curve centred on
4,550Å2, contributes to the [2Mþ 20H]20þ and [2Mþ 21H]21þ
charge states; it contributes more to [2Mþ 21H]21þ Fdc1UbiX
than Fdc1, suggesting that this small conformation is stabilized in
this charge state by the cofactor. The conformer centred on
5,085Å2 (orange) is dominant in all forms of the [2Mþ 20H]20þ
and [2Mþ 21H]21þ charge states. This conformer remains
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Figure 1 | Mass spectrum of Fdc1 and Fdc1Ubix displaying stabilising effects of the prFMN cofactor. (a) Native MS of 5 mM Fdc1 and (b) 10mM
Fdc1UbiX showing some dissociation of the Fdc1 dimer into monomer, while all of the Fdc1UbiX is present as a dimer. This figure has been adapted from
Fig. 5b in the extended data set of Payne et al.2 here, reporting data over a wider m/z range. Both samples were sprayed from 100mM ammonium acetate,
pH 6.8. Right hand spectrum; an enlarged view of [2Mþ 21H]21þ . The measured mass of dimeric Fdc1 is 112,266.4±1.5Da (expected 112,270Da). The
predicted masses are shown by blue dashed lines.
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dominant in the [2Mþ 22H]22þ charge state of Fdc1UbiX, but is
of lower relative intensity in the same charge state of Fdc1,
indicating that the cofactor stabilizes this ‘orange’ conformation
in [2Mþ 22H]22þ . A conformer centred on 5,736Å2 (pink)
makes a minor contribution to all forms of [2Mþ 20H]20þ ,
while to [2Mþ 21H]21þ and [2Mþ 22H]22þ it is of higher
relative intensity in Fdc1 than Fdc1UbiX. The conformer centred
on 6,400Å2 (cyan) is also more intense in the higher-charge states
of Fdc1 than Fdc1UbiX. An additional conformer centred on
7,042Å2 of the [2Mþ 22H]22þ ion is eliminated in the presence
of the cofactor. So while the [2Mþ 20H]20þ ion is similar for
Fdc1 and Fdc1UbiX, in the higher-charge states the ‘orange’
conformation is stabilized by the cofactor, and in the apo form it
is replaced by the ‘pink’ and ‘cyan’ conformations, and an
additional ‘green’ conformation.
MD shows the evolution of Fdc1Ubix in vacuo. To further
explore the conformational dynamics of Fdc1UbiX, we performed
in vacuo MD on the Fdc1UbiX protein in the gas phase, starting
from the crystal structure coordinates (Fig. 3). Results of the MD
simulation are shown in terms of (Fig. 3a) the calculated
exact hard sphere collision cross section (EHSSCCSHe), (Fig. 3b)
the radius of gyration (Rg), (Fig. 3c) the solvent accessible surface
area (SASA) of the protein and (Fig. 3d) the composition of
secondary structural elements. Figure 3 and Supplementary Fig. 2
show the MD data of cofactor-bound Fdc1UbiX at 350 and
300K, respectively. The studies were carried out at different
temperatures to imitate different cone voltages (vide infra).
During the simulation of Fdc1UbiX at 350K (Fig. 3), all
measured parameters signify a collapse in the gas-phase structure.
Between t¼ 0 and t¼ 10 ns, the EHSSCCSHe decreases from 6,240
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Figure 2 | Collision cross section distributions of Fdc1 and Fdc1Ubix. (a) Arrival time distributions of the three main charge states of Fdc1, (b) Fdc1Ubix
with two bound cofactors and (c) with one bound cofactor. The purple curve corresponds to the conformation at 4,550Å2, orange is 5,085Å2, pink is
5,736Å2 and cyan is 6,400Å2. A green curve in the ATD of the apo form of [2Mþ 22H]22þ corresponds to an additional conformational family centred on
7,042Å2, which is eliminated by the presence of the cofactor. (d) ATDs of Fdc1 and Fdc1Ubix at increasing cone voltages with two bound cofactors and one
found cofactor. The peaks shaded grey represent the apo-Fdc1 protein and are overlaid onto each of the forms of Fdc1Ubix protein: blue are holo-1-Fdc1Ubix
and red are holo-2-Fdc1Ubix.
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to 6,143 Å2 and the Rg decreases from 31.7 to 31Å. The surface
area of the complex decreases from 27,000 to 24,000Å2, and to
20,177Å2 for the smallest minimized conformer, representing a
decrease of 11 and 23%, respectively. The interfacial area between
the two monomers as calculated by PISA (Protein Interfaces,
Surfaces and Assemblies)18 decreased by 2% between t¼ 0 and
t¼ 10 ns, and 4% for the smallest model structure indicating little
structural rearrangement at the interface of the complex and
retention of the Fdc1Ubix structure. The total a-helical content
decreases marginally from 26.2 to 23.6%, while the b-sheet
content decreases from 21.2 to 20.3% (Fig. 3d). A selection of
structures were minimized to optimize the position of all atoms,
resulting in significant reduction of the EHSSCCSHe values down
to 5,920Å2 (green dots, Fig. 3a). When MD simulations of
Fdc1UbiX were carried out at 300K (Supplementary Fig. 2),
the reduction in Rg is less pronounced than at 350K, and
the EHSSCCSHe measurements of the minimized structures
correspondingly larger, but again are notably smaller than the
raw crystal structure coordinates. The lowest EHSSCCSHe found
in these short simulations is 5,983 and 5,921Å2 for Fdc1UbiX
at 300 and 350K, respectively. Figure 3e–g and Supplementary
Fig. 2e–g depict three representative structures from each
trajectory. The data here indicates a higher degree of collapse of
the protein at 350K than at 300K.
Following 10 ns of MD and minimization, the EHSSCCSHe of
Fdc1Ubix reduces by 6.1%, to a value that is close to the apex of
the pink conformer observed experimentally, (Fig. 2). This is
similar to previously published findings, where in vacuo MD of
large proteins starting from crystal structure coordinates results
in significant conformational tightening11,19. All IM spectrometry
experiments last significantly longer (milliseconds) than the
nanosecond time scales of these atomistic simulations, allowing
much more time for gas-phase collapse to a tighter packed form.
This closer packing is entirely expected due to the increased
contribution from favourable electrostatic interactions in the
absence of mitigating solvent20, and no competing effects from
repulsive coulombic interactions for the large protein as it
presents with such low z. We also calculated the CCSHe of the
smallest conformation that the Fdc1 dimer could possibly adopt,
by assuming that this conformation is spherical in shape with a
density of r¼ 0.904DaÅ 3 (ref. 9). This smallest theoretical
cross section is 3,430Å2, B14% smaller than the smallest
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Figure 3 | Molecular dynamics trends for the holo-Fdc1 at 350K simulation. (a) Collision cross section (calculated using the ‘Exact Hard Sphere’
method) versus time. The EHSSCCSHe for minimized structures is depicted using the green dots; (b) backbone radius of gyration versus time; (c) solvent
accessible surface area (SASA) versus time; and (d) secondary structure content versus time. Snapshots of: (e) the initial structure at 0 ns; (f) the smallest
found structure by EHSSCCSHe ; and (g) the final structure in the trajectory. The protein structure coloured by the secondary structure features:
a-helix (orange), b-strand (purple) and coil (grey). Protein images made using UCSF Chimera33. Data for holo-Fdc1UbiX at 300K is available in the
Supplementary Fig. 2.
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DTCCSHe measured in our mobility experiments. Our analysis
shows how the conformations of Fdc1 in the gas-phase range
from very compact to more extended, indicative of a flexible
protein in solution, as well as the width of the CCSDs, which
imply that the protein is also changing shape on the time scale of
the mobility experiment. This is supported by our MD
simulations that the protein to sample many conformations
even in 10 ns.
MS and IM-MS probe the influence of prFMN. A key question
is why we observe a proportion of Fdc1Ubix carrying less than two
cofactors. The possible reasons are that (i) this reflects the
cofactor occupancy in solution or (ii) some cofactor dissociates
from the protein during desolvation. The crystal structures2 were
modelled with 100% cofactor occupancy, but whether this reflects
the solution-phase character, or is due to preferential
crystallization of the dimer with two cofactors, remains
unknown. Our IM–MS results show that the different forms of
Fdc1UbiX have similarly shaped DTCCSHe distributions for the
same charge states, regardless of the number of non-covalently
bound cofactors. An explanation for this is that some cofactor is
lost on desolvation, but the protein retains the conformation
adopted when in complex with the cofactor, a templating effect
we have reported previously21 due to the time scale for the
conformational change in the protein complex being significantly
longer than the experimental time scale of the IM–MS
process. This is supported by the fact that in our analysis of
Fdc1UbiX, we are always able to resolve a species at m/z 525 that
corresponds exactly to the mass of the cofactor even under the
most gentle desolvation conditions. Further evidence that the
cofactor is lost during desolvation is found when on modulating
the harshness of the ionization process, we can alter the
proportion of single- and double-cofactor-bound protein
(Supplementary Fig. 3). By increasing the voltage applied
to the sample cone, we cause the protein to experience a larger
potential difference during desolvation, which results in harsher
ionization conditions. When the cone is increased to 200V, the
ratio of the intensities of singly bound to doubly bound isB0.75,
up fromB0.66 at a cone voltage of 60V. This native IM–MS data
indicates that the holo form is dominant and more rigid than the
apo form, but also that prFMN is somewhat labile and can
dissociate from the protein. Under similar nESI–MS conditions, a
haem cofactor has been shown to be fully retained by myoglobin
and haemoglobin22, and FMN similarly is reported to be fully
retained in glutamate synthase23 and flavodoxin24.
Increasing the energy of the ions in the desolvation stage of
the instrument can cause proteins to deform, as well as induce
fragmentation as alluded to above, and we performed such
experiments on Fdc1Ubix and Fdc1. The effect of such
collisional activation on the gas-phase conformation of the
intact complexes is shown in Fig. 2d. As the potential between
the cone and the next sampling orifice is increased, Fdc1 adopts
more elongated conformations between 156 and 213 V of
source potential whereas Fdc1Ubix maintains a more constant
drift time up to the highest potentials applied, strongly
indicative of a more stable conformation. Interestingly,
the single cofactor and cofactor deplete forms of Fdc1Ubix also
retain a compact form to the most elevated voltages, again
suggesting that prFMN is lost at this stage and that the
stabilized holo form of the protein remains, this is also
consistent with the retention of metal ions even in the
prFMN deplete forms as discussed above. MD shows the
behaviour of the cofactor present Fdc1Ubix is highly similar
to simulations performed, where we removed the cofactor
(Fig. 2; Supplementary Fig. 2; and data not shown).
HDX-MS locates conformational change due to prFMN. The
difference in deuterium uptake between Fdc1 and Fdc1UbiX
summed over all time points is reported in Fig. 4a, and the
relative fractional uptake of deuterium at discrete time points for
Fdc1UbiX (top) and Fdc1 (bottom) in Supplementary Fig. 4. The
coverage map and several uptake plots of selected peptides are
shown in Supplementary Figs 5 and 6, respectively, for each form
of the protein 95% coverage was obtained. Across the majority of
the peptides sampled there is an overall increase in mass when
comparing the uptake of Fdc1 against Fdc1UbiX, indicating a
more dynamic structure for Fdc1 in agreement with both MS and
IM–MS experiments. In particular, there is a higher uptake for
Fdc1 in the regions containing residues 187–197, 223–240 and
441–450. X-ray crystallography has shown that H191 is involved
in the binding of Mn2þ and Q190 is involved in the binding of
the cofactor, which correlates with the HDX data.
The fact that the cofactor is not present and that we cannot
observe Mn2þ binding in apo-Fdc1 is a possible explanation for
this apparent destablization/increased solvent exposure of the
apo protein around residues 187–197. E233 is also involved in
Mn2þ binding that could account for the increased dynamics of
residues 223–240. Other residues involved in Mn2þ binding are
N168 and K391, both of which are within regions of increased
uptake for Fdc1 compared with Fdc1UbiX, albeit at a lower level.
E282, E277 and R173 are other residues known to be associated
with the bound cofactor and these are also within regions of
higher HDX in the absence of the cofactor. Interestingly, there are
some regions within Fdc1UbiX that have an increase in deuterium
uptake in comparison with Fdc1: residues 108–123 and 460–465.
The latter areas are in close proximity to regions that have an
increased deuterium uptake for Fdc1, suggesting that in the
absence of prFMN, residues around the cofactor-binding site are
exposed to the solvent, and a conformational switch occurs
driving the regions containing residues 108–123 and 460–465
into the centre of the protein.
Differences in deuterium uptake are visualized by plotting
regions of changed mass at the peptide level onto the crystal
structure of Fdc1UbiX (PDB ID: 4ZA4), with the surface elements
displayed in Fig. 4b and Supplementary Fig. 7, and the secondary
structure elements shown in Fig. 4c. Significant variations in
behaviour are found in close proximity to the cofactor-binding
site (highlighted in Fig. 4d). These tend to be at the end of
a-helices, in regions that are leading to disordered loops,
indicating a change in stability of secondary structure elements
on binding of the cofactor. This can also be seen in
Supplementary Fig. 8. For example, the predominantly hydro-
phobic patch over residues 227–238 has an uptake of 45%,
wherein 227–232 consists of a disordered loop and 233–238 are
part of an a-helix that extends to the glycine (242). It is feasible
that in the apo form the disordered loop extends at least to the
glycine at residue 238 and the helix is correspondingly shorter.
Another region of destablization corresponds to the N-terminal
helix of Fdc1UbiX spanning residues 5–20. There is an uptake in
deuterium of45% from residues 7–16, suggesting a reduction of
secondary structure for this N-terminal region. It is important to
consider that while the most appropriate way to display the
difference in deuterium uptake is to plot it onto the Fdc1UbiX
structure, this will not correspond exactly to that of apo-Fdc1, and
indeed our results show this. It is likely that apo-Fdc1 has reduced
overall secondary structure content compared with the holo form,
due to the location of the uptake differences at the ends of
a-helices, suggesting that these are more dynamic and less
configured in the absence of prFMN.
Uptake increases at short time points for Fdc1 (pink) and
Fdc1UbiX (cyan) are in close proximity to one another, either in
the linear sequence or the position of the areas (Supplementary
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Fig. 7). Visualization of the surface of the crystal structure
(Fig. 4b; Supplementary Fig. 7) illustrates differences in uptake
both close to, and distant from, the cofactor-binding region. This
indicates not only a conformational change in the areas that bind
the cofactor, but also an allosteric change in conformation in
areas distant from the cofactor. This insight to the effect of
prFMN binding is possible, since HDX-MS is an approach that
allows equal visualization of the apo and holo states of this
protein, and how they behave as a function of time, in contrast to
the snapshot of only the holo state found crystallographically.
Conclusions and outlook. Here we have used three MS-based
techniques to delineate how the structure and dynamics of Fdc1
are affected by the binding of prenylated FMN. Native MS results
confirm the stoichiometry of the protein complex; when Fdc1 is
expressed alone (that is, the absence of UbiX overexpression) it is
detected only in the apo form, and presents mainly as a dimer
with a charge state range (Dz) of 5, with some low-intensity
monomer peaks. When Fdc1 is co-expressed with UbiX the
monomer peaks are eliminated, indicating a more stable structure
in the presence of the ligand, since the dimer interaction is
stronger. IM–MS detects four closely related conformational
families centred on DTCCSHe values of 4,550, 5,085, 5,736 and
6,400Å2 that are populated differentially depending on the
presence of the cofactor; the smallest two families are more
dominant in the presence of the cofactor, indicating stabilization
of the compact form of the quaternary fold. The two more
extended families are of higher intensity in apo-Fdc1 than
Fdc1UbiX, demonstrating the more dynamic nature of the
protein in the absence of the cofactor. Further, an additional
conformational family is observed in the CCSD of the apo-Fdc1
[2Mþ 22H]22þ ion at 7,400Å2 that is eliminated in the presence
of the cofactor. The disappearance of peaks corresponding to the
monomeric species in Fdc1UbiX as shown by native MS and the
smaller CCS measurements of Fdc1UbiX c.f. apo-Fdc1 in IM–MS
experiments demonstrate that the cofactor confers stability to the
dimer and promotes more compact conformations. With HDX,
we have (i) observed overall conformational tightening in the
presence of the cofactor in solution and (ii) been able to localize
regions of the protein where the alterations in dynamics occur.
There are changes in deuterium uptake close to the cofactor
binding and Mn2þ -binding sites, suggesting conformational
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differences in these regions. The protein also appears to undergo
allosteric changes in the presence of the cofactor, shown by
differential deuterium uptake in regions distant from the
cofactor-binding site. There is very little change in deuterium
uptake on the dimer interface between the apo and holo forms of
the protein, suggesting that the monomer species observed via
MS are not transferred from solution, and likely arise from
dissociation during the ionization process. Previous to the
research presented in this paper, it was unknown how the
residues moved in response to the cofactor binding. HDX-MS
experiments, however, provide information on the change in
solvent accessibility of localized regions of the protein.
Overall, we have observed differences in the apo and holo
forms of the Fdc1 protein; specifically, the protein is more
dynamic in the apo form and has less rigid tertiary and
quaternary structure. This could not be observed via X-ray
crystallography, since no crystals could be obtained of apo-Fdc1.
This lack of crystallization may be due to the increased flexibility
that we have observed in our experiments. Here we have a
comparison between apo- and holo-Fdc1 that is equally weighted
for both forms of the protein; the data do not preferentially
report on the cofactor-bound form, as for other methods. We
demonstrate the complementarity of MS to crystallographic
approaches and in particular this study emphasizes its benefits in
its use to study dynamic protein complexes and the effect of
cofactors on stabilising protein fold.
Methods
Expression and purification of Fdc1 and Fdc1UbiX. The codon optimized A. niger
fdc1 gene (Genscript) was cloned into the NdeI and XhoI sites of pET30a, while
E. coli ubiX was cloned into the NdeI and XhoI sites of pET21b. A. niger fdc1
pET30a was transformed into E. coli BL21(DE3) with or without ubiX pET21b.
Cells were grown at 37 C/180 r.p.m. in LB broth supplemented with 50 mgml 1
kanamycin (single expressed) or with both 50 mgml 1 kanamycin and 50mgml 1
ampicillin (co-expressed). Cells were induced with 0.25mM IPTG and
supplemented with 1mM MnCl2 at mid-log phase and, grown overnight at
15 C/180 r.p.m. Cells were collected by centrifugation (4 C, 7,000g for 10min)
and the pellets resuspended in buffer A (200mM NaCl, 1mM MnCl2, 50mM
Tris pH 7.5) supplemented with lysozyme, RNase, DNase (Sigma) and complete
EDTA-free protease inhibitor cocktail (Roche). Cells were lysed by French press at
20,000 psi and the lysate clarified by centrifugation at 125,000g for 90min before
being applied to a Ni-NTA agarose column (Qiagen). The column was washed with
three column volumes of buffer A containing 10mM imidazole and the protein
eluted in 1ml fractions with buffer A supplemented with 250mM imidazole.
Fractions containing pure protein were identified by SDS–polyacrylamide gel
electrophoresis analysis, pooled and buffer exchanged using a 10-DG desalting
column (Bio-Rad) equilibrated 100mM NaCl, 1mM MnCl2, 25mM Tris pH 7.5 to
remove the imidazole. The protein concentration of A. niger Fdc1 was estimated
from its absorbance at 280 nm (recorded with a Cary UV–Vis spectrophotometer)
using e280¼ 68,870M 1 cm 1 (calculated from the primary amino-acid
sequence using the ProtParam program on the ExPASy proteomics server).
The protein was aliquoted and flash-frozen until required.
MS experimental conditions. Ten-DG desalting columns (BioRad) were used to
buffer exchange the proteins into 100mM ammonium acetate. Native MS spectra
were acquired on a Synapt G2 instrument (Waters, Manchester, UK) with a nESI
source. Mass calibration was carried out by separately infusing NaI cluster ions.
Solutions were ionized by applying a positive potential through a platinum wire
(thickness 0.125mm, Goodfellow) that was inserted into a thin-walled glass
capillary (inner diameter 0.9mm, outer diameter 1.2mm, World Precision
Instruments, Stevenage, UK) that was pulled to a nESI tip in house with a
Flaming/Brown micropipette puller (Sutter Instrument Co., Novato, CA, USA).
Fdc1 samples (5–10 mM) were sprayed from 100mM ammonium acetate pH, 6.8.
Capillary voltage 1.6 kV, sample cone voltage 80–90V, extractor cone voltage 3 V,
source temperature 50 C, backing pressure 5mbar, Trap gas flow 0.4–5mlmin 1.
Data were processed using MassLynx V4.1 software (Waters, Manchester, UK) and
Origin 9.0 (OriginLab Corporation, USA).
Ion mobility–mass spectrometry. IM–MS is a gas-phase electrophoretic techni-
que that can be coupled to a mass spectrometer. A typical IM experiment involves
ions being trapped and then pulsed into a chamber known as a drift tube, across
which is applied a weak electric field that draws the ions through the tube. The drift
tube is filled with an inert gas, in this case helium, which collides with the ions,
hindering their passage through the drift tube. Larger ions will experience more
frequent collisions with the buffer gas and will hence be slowed down to a greater
extent. By measuring the arrival time of the ion and the charge present on it via
subsequent MS, the rotationally averaged collision cross section can be directly
calculated.
The mobility of an ion (K0) is determined as the ratio of the drift velocity (vd)
and applied electric field (E). The DTCCSHe can then be calculated on the basis of
equation (1);
K0 ¼ 3ze16N
2p
mkBT
 1=2 1
O
ð1Þ
where z is the charge state of the ion, e is the elementary charge, N is the gas
number density, m is the reduced mass of the ion-neutral pair, kB is the Boltzman
constant, T is the gas temperature and K0 is the reduced mobility (the measured
mobility K standardised for pressure and temperature to 273.15 K and 760 torr).
IM–MS experiments were carried out on a Waters Q-ToF I instrument that was
previously modified in house to include a 5.1-cm drift tube that has been described
elsewhere10. nESI was used to produce ions, with a capillary voltage of 1.6 kV and a
source temperature of 80 C. Tips were prepared as above. The pressure and
temperature of helium in the drift cell were B4 torr and 30 C, respectively.
Measurements were recorded at six different drift voltages from 50 to 20V. The
precise pressure and temperature was recorded for every drift voltage and used in
the calculations of DTCCSHe values. Each experiment was performed in triplicate.
Data were analysed using MassLynx v4.1 software, Origin 9.0 and Microsoft Excel.
Ion arrival time distributions were recorded by synchronisation of the release of
ions into the drift cell with mass spectral acquisition.
The DTCCSHe distribution plots are derived from raw arrival time data using
equation (2) below25.
Oavg ¼ 18pð Þ
1=2
16
1
mb
þ 1
m
 1=2 ze
KBTð Þ1=2
1
r
tdV
L2
ð2Þ
Where m and mb are the masses of the ion and buffer gas, respectively; z is the ion
charge state; e is the elementary charge; KB is the Boltzmann constant; T is the gas
temperature; r is the buffer gas density; L is the drift tube length; V is the voltage
across the drift tube; and td is the drift time.
The raw arrival time output (ta) includes time the ions spend outside of the drift
cell, but within the mass spectrometer, known as the dead time (t0). The value for t0
is calculated by taking an average value of the intercept from a linear plot of
average arrival time versus pressure/temperature and was subtracted from the
arrival time to calculate drift time (tD):
tD ¼ ta  t0 ð3Þ
Modelling of smallest possible CCS. This procedure has been described
elsewhere9. In brief, the lower boundary was calculated by assuming that the
globular form of the protein is approximately spherical in shape with a density
of r¼ 0.904DaÅ 3. The volume of the protein sphere can be calculated via
V¼Mw/r, since the molecular weight Mw of the protein is also known. The radius
of the sphere is therefore r¼ (3V/4p)1/3. The CCS of a sphere of this radius is given
by equation 4:
CCSlower A˚
2
 
¼ pr2 ¼ p 3V
4p
 2=3
ð4Þ
A scaling factor of 1.19 is then applied to this value for the conversion from
geometric size to CCS in helium as outlined in ref. 26. These theoretical values are
highly approximate and do not take into consideration proline residues, disulphide
bridges, or other non-covalent interactions or restrictions. Instead, they serve as
upper and lower boundaries with which experimental data can be compared.
Homology modelling of Fdc1. The starting structure was obtained from RCSB
Protein Data Bank (PDB ID: 4ZA4)2, missing residues were modelled using
MODELLER based on the sequence alignment obtained from BLAST27. The
resultant protein models were subsequently minimized and the most energetically
favourable structure was selected for further computational simulations.
Parameterization of prFMN ligand. Simulation parameters for the
prFMN cofactor were derived by calculating atomic charges from multiple
conformations using RED server according to the RESP model28. Ligand
parameters were generated using antechamber module in Amber 14 (ref. 29).
Molecular dynamics. MD simulations were performed using the sander module
in Amber 14 for Fdc1UbiX. After adding hydrogen atoms, the protein was
minimized in vacuo using an ‘infinite’ radial cutoff of 999Å and the amber14SB
force field was used. The system was then gradually heated to 300 and 350K
using a weak coupling coefficient of 2 ps 1 with a time step of 2 fs. The SHAKE
algorithm was used on all bonds involving hydrogen atoms. Following heating and
equilibration, 10 ns of dynamics was carried out for each protein at 300 and 350K;
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the higher temperature was chosen to imitate harsher ionization conditions the ion
might experience at high cone voltage. The MD results were analysed using the
cpptraj module. The conformational rearrangement of the dimer was monitored
using the backbone Rg, SASA, secondary structure (DSSP)30 and PISA area in
CCP4 (refs 18,31).
Calculation of CCSs. Theoretical collision cross sections were calculated for each
MD frame (every 2 ps) using the exact hard sphere model, as implemented in
EHSSrot software32. A subset of structures was selected based on the Rg, SASA and
initial EHSSCCSHe values; a total of 60–70 structures were selected for further
energy minimization from each simulation run. The resulting minimized structures
were then re-evaluated using the EHSS method to determine their corresponding
EHSSCCSHe.
HDX-MS experimental conditions. Fdc1 and Fdc1UbiX solutions were prepared at
20mM. Deuterium labelling and quenching were automatically performed using the
CTC PAL sample manager (LEAP Technologies, Carrboro, NC, USA). The sam-
ples were first diluted 20-fold with 10mM phosphate in 99.99% deuterium oxide,
pH 6.6 (pD 7.0), and incubated for 0, 0.25, 5, 60 and 240min at 20 C. Quenching
of the labelled samples was by the addition of an equal volume of pre-chilled
100mM phosphate pH 2.5. All labelling time points were analysed in triplicate.
A measure of 50 ml of sample was injected on a nanoACQUITY UPLC system with
HDX technology (Waters). Online pepsin digestion was performed for 1min at
20 C on a Waters Enzymate immobilized BEH pepsin column (2.1 30mm). The
peptides were separated on a UPLC BEH C18 column (Waters) at 0 C. Peptides
were separated with a 7-min linear acetonitrile gradient (8–35%) containing 0.1%
formic acid at 40ml min 1. Mass spectra were acquired on a SYNAPT G2-Si
HDMS in MSE mode with a m/z range of 50–2,000. Non-deuterated peptides were
identified with ProteinLynx Global Server software 3.1 (Waters). DynamX 2.0
software (Waters) was used to filter the peptides and to generate deuterium uptake
data. Origin 9.0 was used to create the plots.
Data availability. The data and the essential metadata that support this study are
available from the corresponding author on request.
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